What to know about FDA’s review of new Zyn advertising proposal

Americans who smoke may soon be hearing a lot more about Zyn. That's the flavored nicotine pouch that's generated billions in ...

Legal questions swirl around FDA’s new expedited drug program, including who should sign off

A plan to slash Food and Drug Administration drug review times is raising alarms at the public health agency that's been ...
MM&M

Two new Untitled Letters, multiple close-outs: Latest on FDA’s pharma ad crackdown

The Food and Drug Administration has continued its pharma ad crackdown by issuing a pair of new Untitled Letters and releasing a series of close-out letters indicating drugmakers have made changes to ...
CBS News

Inside the FDA's vaccine uproar

Dr. Céline Gounder, an internist, epidemiologist and infectious disease specialist, is a CBS News medical contributor as well as senior fellow and editor-at-large for public health at KFF Health News.
Healio

FDA declines to approve relacorilant for hypertension linked to hypercortisolism

Please provide your email address to receive an email when new articles are posted on . The FDA issued a complete response letter for relacorilant to treat hypertension tied to hypercortisolism. The ...
The National Law Review

FDA and USDA Enforcement of HACCP

LUNENBURG, NS, CANADA, October 27, 2025 /EINPresswire.com/ -- Both the USDA and FDA oversee HACCP. The USDA's Food Safety and Inspection Service (FSIS) oversees the ...
Medical Xpress

FDA may reduce how often supplement warnings appear on labels

The U.S. Food and Drug Administration (FDA) is weighing a change that could make warning labels on dietary supplements appear less often on packaging. Unlike prescription drugs, dietary supplements ...